|
FBXW2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.643380E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.642700E-04 |
| Normal-vs-Stage2 |
3.239200E-01 |
| Normal-vs-Stage3 |
1.774400E-02 |
| Normal-vs-Stage4 |
1.466150E-01 |
| Stage1-vs-Stage2 |
4.874400E-01 |
| Stage1-vs-Stage3 |
6.297800E-01 |
| Stage1-vs-Stage4 |
7.219800E-01 |
| Stage2-vs-Stage3 |
3.371400E-01 |
| Stage2-vs-Stage4 |
4.426800E-01 |
| Stage3-vs-Stage4 |
9.674600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.798400E-04 |
| Normal-vs-AfricanAmerican |
2.555400E-01 |
| Normal-vs-Asian |
5.638000E-02 |
| Caucasian-vs-AfricanAmerican |
2.620000E-01 |
| Caucasian-vs-Asian |
2.892600E-01 |
| AfricanAmerican-vs-Asian |
1.864430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.35160000000057E-05 |
| Normal-vs-Female |
7.093000E-01 |
| Male-vs-Female |
3.710100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.676120E-02 |
| Normal-vs-Extreme_Weight |
1.203760E-04 |
| Normal-vs-Obese |
4.075600E-01 |
| Normal-vs-Extreme_Obese |
1.427750E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.035200E-01 |
| Normal_Weight-vs-Obese |
1.712550E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.520200E-01 |
| Extreme_Weight-vs-Obese |
3.334200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.742400E-01 |
| Obese-vs-Extreme_Obese |
3.855600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.859800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.183200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.07619999999365E-05 |
| Normal-vs-Age(81-100Yrs) |
4.739200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.740400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.317000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.775010E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.632480E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.132100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.119400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.345600E-02 |
| Normal-VS-Type2 PRCC |
4.06569999999995E-05 |
| Normal-VS-KIRP CIMP |
9.649000E-01 |
| Normal-VS-Unclassified PRCC |
3.531600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.043800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.128200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.093200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.408400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.489600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.596000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.43360000004478E-06 |
| Normal-vs-N1 |
3.299000E-01 |
| Normal-vs-N2 |
4.307600E-01 |
| N0-vs-N1 |
1.147840E-01 |
| N0-vs-N2 |
5.888000E-01 |
| N1-vs-N2 |
7.472800E-01 |
|
|
